Fingerprint
Dive into the research topics of 'Phase 2 Study of the Safety and Antitumor Activity of Apalutamide (ARN-509), a Potent Androgen Receptor Antagonist, in the High-risk Nonmetastatic Castration-resistant Prostate Cancer Cohort'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically